Sus Clinicals Appoints Dr. Lawrence Schook to Board of Directors
Sus Clinicals, Inc. announced today that Dr. Lawrence Schook has been elected to the Company’s Board of Directors
Read article 
Sus Clinicals, Inc. Announces $2 Million Research Grant from the National Institutes of Health
Funding will support breakthrough work against an aggressive form of liver cancer
Read articleSus Clinicals, Inc. Announces Former Jackson Labs Executive Joins the Company as Advisor
Dr. Auro Nair brings over three decades of experience in life sciences and biomedical research
Read article Sus Clinicals, Inc. Announces Formation of Advisory Council
Top experts to advise Company on scientific priorities and innovation strategies
Read articleSus Clinicals Announces Former McKinsey Executive Joins the Company as Advisor
Jeff Sinclair brings 30+ years of experience in strategy, operations and organization design
Read articleSus Clinicals, Inc. Receives Clearance from the U.S. Food & Drug Administration
Grant of Enforcement Discretion Supports Commercial Launch
Read articleSus Clinicals, Inc. Announces New License Agreement for Advancement in Cancer-Related Research
Patent-Pending Technology from the University of Illinois Leverages Large Animal Model to Accelerate Pre-Clinical Testing for Cancer Therapies
Read article
